U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H36N2O4.C4H4O4
Molecular Weight 508.6044
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ARTEROLANE MALEATE

SMILES

OC(=O)\C=C/C(O)=O.CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OOC3(O2)C4CC5CC(C4)CC3C5

InChI

InChIKey=SVDSPJJUJMMDFX-CXCXETQFSA-N
InChI=1S/C22H36N2O4.C4H4O4/c1-20(2,23)13-24-19(25)12-14-3-5-21(6-4-14)26-22(28-27-21)17-8-15-7-16(10-17)11-18(22)9-15;5-3(6)1-2-4(7)8/h14-18H,3-13,23H2,1-2H3,(H,24,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15?,16?,17?,18?,21+,22?;

HIDE SMILES / InChI

Molecular Formula C22H36N2O4
Molecular Weight 392.5322
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Arterolane is an anti-malarial drug developed by Ranbaxy Laboratories. Arterolane belongs to peroxidic antimalarial compounds. Upon administration, the drug is activated by heme of hemoglobin digested by malarial parasite. Activation produces free radicals, leading to alkylation of heme and proteins, critical for the survival of the parasite. Arterolane was approved for marketing in India in 2012 and received marketing authorization in several African countries in 2014.

Approval Year

PubMed

PubMed

TitleDatePubMed
Comparative embryotoxicity of different antimalarial peroxides: in vitro study using the rat whole embryo culture model (WEC).
2010-12
Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.
2010-09-15
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
2010-01-14
Development and validation of a headspace gas chromatographic method for the determination of residual solvents in arterolane (RBx11160) maleate bulk drug.
2010-01
Simultaneous determination of OZ277, a synthetic 1,2,4-trioxolane antimalarial, and its polar metabolites in rat plasma using hydrophilic interaction chromatography.
2009-10-01
The future of artemisinins: natural, synthetic or recombinant?
2008-12-15
In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.
2008-11
Drug metabolism and pharmacokinetics.
2008-10
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277.
2008-03-01
In vitro susceptibility of P. falciparum populations from Colombia and Tanzania to a new synthetic peroxide (OZ277).
2007-06
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
2007-03
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
2006-07
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
2006-07
Infectious diseases. Source of new hope against malaria is in short supply.
2005-01-07
[Artemisinin and successors].
2005
Synthetic antimalaria drug enters clinical trials.
2004-10
Identification of an antimalarial synthetic trioxolane drug development candidate.
2004-08-19
Substance Class Chemical
Created
by admin
on Wed Apr 02 03:37:57 GMT 2025
Edited
by admin
on Wed Apr 02 03:37:57 GMT 2025
Record UNII
1C86ZU1OEN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Arterolane maleate [WHO-DD]
Preferred Name English
ARTEROLANE MALEATE
Common Name English
DISPIRO(CYCLOHEXANE-1,3'-(1,2,4)TRIOXOLANE-5',2''-TRICYCLO(3.3.1.13,7)DECANE)-4-ACETAMIDE, N-(2-AMINO-2-METHYLPROPYL)-, CIS-, (2Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
Code System Code Type Description
CAS
959520-73-1
Created by admin on Wed Apr 02 03:37:57 GMT 2025 , Edited by admin on Wed Apr 02 03:37:57 GMT 2025
PRIMARY
FDA UNII
1C86ZU1OEN
Created by admin on Wed Apr 02 03:37:57 GMT 2025 , Edited by admin on Wed Apr 02 03:37:57 GMT 2025
PRIMARY
SMS_ID
300000039291
Created by admin on Wed Apr 02 03:37:57 GMT 2025 , Edited by admin on Wed Apr 02 03:37:57 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY